Senlizumab
Based on 1 Customer Validation
Senlizumab is a humanized antibody expressed in CHO cells that targets TNFSF2/TNFa. Senlizumab is composed of huIgG4SP heavy chains and huκ light chains, with a predicted molecular weight (MW) of 146.9 kDa. The isotype control for Senlizumab can refer to Human IgG4 kappa, Isotype Control (HY-P99003).
For research use only. We do not sell to patients.
- Purity: 95.09%
- CAS No.: 336128-48-4
- Molecular Weight:146.868 kDa
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Human IgG4 kappa
Human
TNFSF2/TNFa
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
ELISA, FACS, Functional assay
-
Immobilized TNF-alpha/TNFSF2 Protein, Human (HY-P7058) can bind Senlizumab. The EC50 for this effect is 38.20 ng/mL.
Chemical Information
-
CAS No. 336128-48-4
-
Appearance Liquid
-
Molecular Weight 146.868 kDa
-
Color Colorless to light yellow
-
SMILES
[Senlizumab]
-
Synonyms
BAY-103356; CDP-571
-
Shipping
Shipping with dry ice.
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
-
Data Sheet (230 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Inhibitory Antibodies User Guide (603 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)